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Molecular docking and molecular mechanics simulations are important approaches 
to achieve a rational drug design or a chemical process modeling. It goes to deep molecu-
lar insights as structures and mechanisms helping researchers to characterize various 
conformations and molecular interactions in terms of energy and binding affinities, 
giving the possibility to search among dozens, hundreds of real or imaginary com-
pounds, the most suitable for a precise, well-defined purpose. The biochemical purpose 
derives from the chosen macromolecular target, protein, or enzyme. Starting from a 
known substance with a known mechanism of action and biological activity, we can 
imagine other related compounds as drug candidates with better efficacy and fewer side 
effects. These in silico methods help us to identify and select among large compound 
libraries the most suitable therapeutic agent before even starting its chemical synthesis. 
That can be called virtual chemistry before reaction tube. It is very convenient, reducing 
the consumption of chemical reagents, preclinical, clinical trials, and time.
The purpose of this book project is to clearly explain the principles of molecular 
docking and molecular dynamics, with examples of algorithms and procedures pro-
posed by different software programs for small molecule-protein or protein-protein 
complexes of medical or materials sciences interest.
Molecular docking studies provide us an overview of type of interactions occur-
ring in ligand (small molecule)-protein or protein-protein complexes and rank the 
candidate poses by their affinity scoring function.
The concept of molecular recognition of ligand at the protein/enzyme active site, 
classically named “lock and key,” has been extended at “hand and glove,” considering 
the protein flexibility and reciprocal adaptability between the receptor and ligand [1].
Molecular dynamics simulations explore extrinsic surface and bulk properties of 
various forms of pharmaceutically active molecules to aid the selection of a success-
ful candidate. It involves accurate evaluation of binding pathways, kinetics, and 
thermodynamics of ligands in different solvents.
Both these computer-aided drug design (CADD) methods lead to ligand 
identification and optimization, favoring rapid development of pharmaceutical 
compounds.
1. Molecular docking approaches and challenges
Different software algorithms use various approaches such as rigid protein or 
flexible protein, rigid receptor, soft receptor, flexible side chains, induced fit, or 
multiple structure algorithms [2].
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The steps for conducting molecular docking studies are:
• Ligand preparation consists in generation, optimization, and analysis of its 
3D structure. Among multiple conformers, the most stable, as lowest energy, 
can be used for docking simulations. An aspect to be considered is the fact 
that in physiological media, the ligand appears ionized. The effect of solvation 
due to the surrounded water molecules must be solved. The presence of active 
site water molecules influences the docking pose of the ligand and makes 
questionable the accuracy of the method [2]. Three-dimensional structures 
of small ligand molecules are available in virtual databases such as Cambridge 
Structural Database (CSD), Available Chemical Directory (ACD), MDL Drug 
Data Report (MDDR), or National Cancer Institute Database (NCI).
• Receptor preparation. The use of a rigid target protein will conduct a single 
conformation of the receptor. Flexible protein involves different conformations 
to bind the ligand. Often the site water molecules are removed before perform-
ing a docking simulation.
Protein Data Bank (https://www.rcsb.org/) provides various solved 3D structures 
of protein, protein fragments, nucleic acids, and protein-ligand complexes. The assem-
blies are characterized by X-ray crystallography, nuclear magnetic resonance (NMR), 
infrared spectroscopy, and or/electron density and are available as PDB files format. 
This online tool allows us to explore and analyze the structures or to compare any 
protein in the PDB archive, including support for rigid-body and flexible alignments.
Also, for simulation the optimized ligand structure must be imported and used 
in the docking software as *.pdb or compatible file.
• Identify the binding site: This step plays a key role in structure-based drug 
design. It can be determined experimentally or computationally. Some soft-
ware are created to identifying and analyzing binding sites and predicting 
receptor druggability [3].
• Dock ligands: Different algorithms are used, fragment-based algorithms, 
genetic algorithm, Monte Carlo algorithms, and molecular dynamics protocols.
• Docking validation and results analysis: For validation, the software must 
reproduce the real binding site that was founded and characterized by 
X-ray crystallography or NMR techniques. To dock ligand similar derivative 
structures, the same binding site is used, and different conformation dues 
to rotations around flexible bond are performed for each new structure. The 
results conduct to predicting preferential binding orientation and the strength 
of binding affinity, interactions (type, strength, bond length); the conforma-
tions are ranked by mean of scoring functions [or root-mean-score deviation 
(RMSD)]. Furthermore, the stability of receptor-ligand complexes is assessed, 
and ligand/pharmaceutical small compound druggability is evaluated.
Pharmaceutical applications
• Exploring DNA binding properties of some malignant tumor chemothera-
peutic agents [4–7] (to identify the DNA binding site, to predict interactions 
between potential therapeutic compound and DNA, to assess the stability 
of DNA-complexes, and to establish correlations between structure and 
cytotoxicity).
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• In silico modeling as attempts to find new efficient therapeutic compounds 
against pathogens, causative agents of infectious disorders, antitubercular 
drugs [8–11], antibiotics agents against Escherichia coli [12–14], Pseudomonas 
aeruginosa [14–16], Staphylococcus aureus [13, 14, 16–19], Bacillus cereus  
[13, 16], Klebsiella pneumoniae [13], or others.
The computational findings must be completed and confirmed by biological 
assays to determine in vitro activity, by measuring minimum inhibitory concentra-
tion against tested microorganisms.
Molecular dynamics (MD) simulations are useful approaches when analysis 
of thermodynamic and kinetic properties of ligand-binding events is required to 
consider. Besides, MD has become effective tools used to modeling chemical pro-
cesses and to evaluating different parameters of materials in different media (water 
or gas): velocity direction of removal of material electrical discharge machining 
(EDM) [20], indentation [21], wear and friction [22], nano-cutting [23], and laser 
machining [24].
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